Medtronic Forecast, price target & analysts
Medtronic Target price 2025 - Analyst rating & recommendation
Medtronic Classifications & Recommendation:
Medtronic Price Target
| Target Price | $103.02 |
| Price | $105.02 |
| Deviation |
1.90%
register free of charge
|
| Number of Estimates | 30 |
|
30 Analysts have issued a price target Medtronic 2026 .
The average Medtronic target price is $103.02.
This is
1.90%
register free of charge
$120.75
14.98%
register free of charge
$81.81
22.10%
register free of charge
|
|
| A rating was issued by 39 analysts: 20 Analysts recommend Medtronic to buy, 17 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Medtronic stock has an average upside potential 2026 of
1.90%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Apr '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 33.54 | 36.21 |
| 3.62% | 7.97% | |
| EBITDA Margin | 24.99% | 28.81% |
| 3.52% | 15.27% |
36 Analysts have issued a sales forecast Medtronic 2026 . The average Medtronic sales estimate is
This results in the following potential growth metrics:
22 Analysts have issued an Medtronic EBITDA forecast 2026. The average Medtronic EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Apr '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 3.61 | 5.68 |
| 30.80% | 57.34% | |
| P/E | 18.48 |
36 Analysts have issued a Medtronic forecast for earnings per share. The average Medtronic EPS is
This results in the following potential growth metrics and future valuations:
Current Medtronic Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Truist Securities |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 20 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| Goldman Sachs |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| Baird |
Locked
➜
Locked
|
Locked | Nov 19 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Truist Securities:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 20 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
Goldman Sachs:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 19 2025 |
|
Locked
Baird:
Locked
➜
Locked
|
Nov 19 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
